DekaBank Deutsche Girozentrale’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $306K | Hold |
87,000
| – | – | ﹤0.01% | 1061 |
|
|
2025
Q1 | $198K | Hold |
87,000
| – | – | ﹤0.01% | 1113 |
|
|
2024
Q4 | $255K | Hold |
87,000
| – | – | ﹤0.01% | 1111 |
|
|
2024
Q3 | $224K | Hold |
87,000
| – | – | ﹤0.01% | 1145 |
|
|
2024
Q2 | $249K | Hold |
87,000
| – | – | ﹤0.01% | 1124 |
|
|
2024
Q1 | $389K | Hold |
87,000
| – | – | ﹤0.01% | 1051 |
|
|
2023
Q4 | $511K | Hold |
87,000
| – | – | ﹤0.01% | 1034 |
|
|
2023
Q3 | $403K | Hold |
87,000
| – | – | ﹤0.01% | 1066 |
|
|
2023
Q2 | $571K | Hold |
87,000
| – | – | ﹤0.01% | 1001 |
|
|
2023
Q1 | $642K | Hold |
87,000
| – | – | ﹤0.01% | 965 |
|
|
2022
Q4 | $867K | Hold |
87,000
| – | – | ﹤0.01% | 916 |
|
|
2022
Q3 | $850K | Hold |
87,000
| – | – | ﹤0.01% | 912 |
|
|
2022
Q2 | $865K | Sell |
87,000
-100,000
| -53% | -$994K | ﹤0.01% | 905 |
|
|
2022
Q1 | $1.82M | Sell |
187,000
-8,000
| -4% | -$78K | ﹤0.01% | 778 |
|
|
2021
Q4 | $2.65M | Buy |
+195,000
| New | +$2.65M | 0.01% | 712 |
|